CDK2 and esophageal squamous cell carcinoma: Owing to CyclinE and Cyclin-dependent kinases 2, 4 and 6 (CDK2/4/6) are key regulators in the G1 phase, we next determined the expression levels of indicated regulators in FCL-treated ESCC cells (17).